|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 121.07 USD | -1.87% |
|
-4.09% | +5.87% |
| Dec. 12 | Wolfe Research Downgrades Xylem to Peer Perform From Outperform | MT |
| Dec. 11 | Stifel Adjusts Price Target on Xylem to $166 From $172, Keeps Buy Rating | MT |
| Capitalization | 29.97B 28.62B 26.74B 23.65B 42.62B 2,542B 47.06B 330B 122B 1,047B 113B 110B 4,573B | P/E ratio 2024 * |
37.3x | P/E ratio 2025 * | 30.2x |
|---|---|---|---|---|---|
| Enterprise value | 30.55B 29.18B 27.26B 24.1B 43.45B 2,591B 47.97B 337B 125B 1,067B 115B 112B 4,661B | EV / Sales 2024 * |
3.6x | EV / Sales 2025 * | 3.34x |
| Free-Float |
93.14% | Yield 2024 * |
1.18% | Yield 2025 * | 1.25% |
More valuation ratios
* Estimated data
More news
Last Transcript: Xylem Inc.
More recommendations
More press releases
More news
| 1 day | -1.87% | ||
| 1 week | -5.07% | ||
| Current month | -4.48% | ||
| 1 month | -2.86% | ||
| 3 months | -6.78% | ||
| 6 months | -12.60% | ||
| Current year | +5.87% |
1 week
120.76
130.33
1 month
120.76130.33
Current year
109.39146.08
1 year
106.52146.08
3 years
72.08146.08
5 years
54.62146.08
10 years
29.90146.08
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Pine
CEO | Chief Executive Officer | 52 | 2023-12-31 |
William Grogan
DFI | Director of Finance/CFO | 45 | 2023-09-30 |
Thomas Pettit
COO | Chief Operating Officer | 55 | 2022-10-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Victoria Harker
BRD | Director/Board Member | 59 | 2011-10-30 |
Robert Friel
CHM | Chairman | 68 | 2020-04-30 |
Jerome Peribere
BRD | Director/Board Member | 70 | 2013-04-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.28% | 10 M€ | +6.14% | - | |
| 0.97% | 1 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -1.87% | -5.07% | +12.41% | -1.41% | 29.97B | ||
| -0.56% | -2.00% | +55.76% | +114.02% | 88.35B | ||
| -0.26% | -2.43% | +37.09% | +70.20% | 40.98B | ||
| +0.08% | -0.94% | +38.57% | +17.51% | 27.6B | ||
| -1.85% | -2.54% | +8.72% | +2.22% | 27.16B | ||
| -2.29% | -5.41% | +35.62% | -36.09% | 25.71B | ||
| +0.73% | +3.96% | +3.16% | -13.77% | 25.24B | ||
| -0.05% | -1.99% | +26.53% | +63.55% | 18.68B | ||
| -0.64% | -2.33% | +23.30% | +34.60% | 18.14B | ||
| -0.84% | -0.43% | +60.81% | +43.96% | 18.04B | ||
| Average | -0.76% | -1.18% | +30.20% | +29.48% | 31.99B | |
| Weighted average by Cap. | -0.73% | -1.32% | +34.80% | +46.22% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 8.49B 8.11B 7.57B 6.7B 12.07B 720B 13.33B 93.52B 34.62B 297B 31.87B 31.18B 1,295B | 8.92B 8.52B 7.96B 7.04B 12.68B 756B 14B 98.25B 36.37B 312B 33.48B 32.76B 1,361B |
| Net income | 790M 754M 704M 623M 1.12B 66.96B 1.24B 8.7B 3.22B 27.58B 2.96B 2.9B 120B | 992M 948M 885M 783M 1.41B 84.16B 1.56B 10.93B 4.05B 34.67B 3.73B 3.64B 151B |
| Net Debt | 579M 553M 517M 457M 824M 49.13B 910M 6.38B 2.36B 20.24B 2.18B 2.13B 88.38B | -178M -170M -159M -140M -253M -15.07B -279M -1.96B -725M -6.21B -667M -653M -27.11B |
More financial data
* Estimated data
Employees
23,000
Calendar
2025-01-29
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-12 | 121.07 $ | -1.87% | 1,577,565 |
| 24-12-11 | 123.38 $ | -4.04% | 2,274,064 |
| 24-12-10 | 128.57 $ | -0.60% | 1,767,305 |
| 24-12-09 | 129.35 $ | +2.36% | 1,933,658 |
| 24-12-06 | 126.37 $ | +0.11% | 980,211 |
Delayed Quote Nyse, December 12, 2024 at 04:00 pm EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
123.38USD
Average target price
148.57USD
Spread / Average Target
+20.42%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- XYL Stock